close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
Investment
2 mins to read

Vaccinations boost Green Cross profit guidance

Green Cross’s healthcare centres, pharmacies involved in vaccination and testing programmes.

Andrew Bevin Tue, 25 Jan 2022

Covid jabs and swabs have pushed NZX-listed Green Cross Health’s full-year financial expectations up substantially, with the company forecasting a profit between $21.3 million and $23.3m.

Green Cross operates as Unichem, Life Pharmacies, The Doctors medical centres, Total Care Health community

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Andrew Bevin Tue, 25 Jan 2022
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Vaccinations boost Green Cross profit guidance
Investment,
90286
true